Dr. Joseph I. Clark, MD

Dr. Clark practices at Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois.

Dr. Clark's NPI, 1972580843, was assigned on December 30, 2005. Dr. Clark graduated from Loyola University of Chicago, Stritch School of Medicine in 1989. Dr. Clark holds Illinois license 36083048.

Dr. Clark's primary practice is Loyola Medicine Pediatric Mobile Health Unit, at 2160 S 1st Avenue, Maywood, IL 60153. The practice phone is (708) 216-3299.

Dr. Clark's primary practice is Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois. Dr. Clark is also affiliated with Loyola University Medical Center. The medical group on file is Loyola University Medical Center. Dmand AI also links Dr. Clark to 3 more hospitals and 1 home health agency, each named with a free account. Dr. Clark's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clark practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Clark's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Clark is licensed in Illinois.

CMS data shows 1,301 Medicare services from Dr. Clark across 11 procedure codes in 2024, for 340 Medicare patients. Medicare paid $72,722 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 340 Medicare patients who saw Dr. Clark in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clark's median patient age at 72, with 35% women.

In 2024, Dr. Clark wrote 1,114 Medicare Part D claims for 169 patients. 64% of them were for generic drugs. CMS names the drug for 971 of them, across 22 drugs with 11 or more claims each, at $4,853,576 in total drug cost. In 2023, CMS named 741 claims across 20 drugs.

Dr. Clark accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Dr. Clark, published from 2003 to 2025. 2015 was the busiest year, with 4. The most frequent topics are Melanoma, Head and Neck Neoplasms and Neoplasm Metastasis. Dr. Clark has published most often in Cancer. Dr. Clark's most frequent co-authors are Brendan David Curti, MD, David Francis McDermott, MD and Howard L. Kaufman, MD.

Dmand AI links Dr. Clark to 10 clinical trials, 5 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Carcinoma, Renal Cell. National Cancer Institute (NCI) sponsors the most, 8.

CMS Open Payments shows 96 general payments to Dr. Clark from 7 drug and device companies from 2016 to 2022. Speaker and faculty fees make up the largest share, 77% of the total. Bristol-Myers Squibb Company paid the most, $70,655.

Dr. Clark graduated from Loyola University of Chicago, Stritch School of Medicine in 1989.